Want to explain how you spend $800 million [healthcare-economist.com] on clinical tests?
I would, but the link you posted pretty much already has. You do several phases of clinical trials for efficacy and short and long term side effects over the course of 7.5 years. You then perform your estimate of the cost by rolling the cost failed drugs into that $800M total (not sure what percentage of them fail, but if it's a lot, that skews the number pretty heavily) and then you assume a 9% cost of capital, which results in a final number about twice what the actual dollar outlay is.
So the short answer is, you don't actually spend $800M on clinical tests. You spend less than half that (probably significantly less, given the number of drugs that fail partway through).
My question to you is, how do you think they'd piss away $800M doing anything but expensive clinical tests? Paperwork? I find it much easier to explain an $800M hole in a budget if I can point to doctors, hospitals, insurance, and lab facilities than if the only thing I can appeal to is, "I have *so much* paperwork to do. It's crazy!"
It doesn't cost anything like that to go through the approval process in France, Germany, Japan, etc.
Really? How much does it cost? Do those estimates also include the cost of failed drugs and assume a 9% cost of capital?
Further, don't those countries also have rigorous drug approval standards? How does that support your contention that we're better off without any government body approving drugs? If true, it sounds more like an argument to figure out what we're doing wrong with our regulatory system than an argument to scrap it.